Panelists will explore the current state of cannabis legalization in various regions throughout the Americas and highlight emerging markets with high growth potential. Attendees will leave this panel with a deeper understanding of the current state and future potential of emerging cannabis markets in the Americas, as well as insights and strategies for success in these exciting and rapidly evolving markets.
Medical Cannabis: Overview of Emerging Legal Issues and their Impact on the International Market. The international panel of experts will notably discuss the differences in regulations between medical cannabis and pharmaceutical cannabis, how IP is becoming an essential topic with pharmaceutical cannabis medicines, and how it could also impact medical cannabis in the short run.
Canada: What Federal Legalization Looks Like 4 years Later and What Have We Learned. This panel explores and reflects on the legislative updates, regulatory challenges, and business opportunities that have evolved over the past four years of federal cannabis legalization in Canada.
Interstate Commerce in Theory: Raich, the Dormant Commerce Clause, and How Challenges to Social Equity Programs Could Impact Interstate Cannabis Commerce. From the Supreme Court's decision in Raich v. Gonzales to recent challenges regarding state-level importing and exporting restrictions, the Constitution's Commerce Clause has played a critical role in shaping the legal cannabis industry. Our panel of legal experts will dive deep into the precedential cases and discuss recent dormant Commerce Clause challenges to the constitutionality of social equity programs nationwide.
Global Cannabis Intellectual Property Symposium 2023 session: Ethics: Balancing Activism and Zealous Advocacy with the Boundaries of the Profession and Evolving Law
Learn about the hemp-derived Minnesota Model and how it is viewed as a preview to what will happen on the federal level. As goes Minnesota, so goes the rest of the nation? Join local and national speakers for their analysis and predictions, who will also discuss novel/intoxicating hemp-derived cannabinoids and their regulation under both state and federal law, including Delta-8 THC, THC-O, and others.
Join us for a discussion that focuses on the international legislative mechanisms that regulated countries have used to address their obligations under the UN Single Convention.
This session will provide you with practice and practical advice on how to conduct due diligence on an IP portfolio in various types of transactions. The panel will identify top diligence issues so you can spot them in the next transaction you handle, and we'll discuss how to address them.